Inactive Instrument

Analyst Reco. APTINYX

Equities

APTX

US03836N1037

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

HC Wainwright Downgrades Aptinyx to Neutral From Buy	07/03/23	MT
SVB Securities Downgrades Aptinyx to Market Perform From Outperform, Price Target is $0.50	01/03/23	MT
US Futures Lower Following Rate Hike, Ahead of Jobless, PMI Data	03/11/22	MT
HC Wainwright Adjusts Price Target on Aptinyx to $1 From $2, Reiterates Buy Rating	26/08/22	MT
Cowen Downgrades Aptinyx to Market Perform From Outperform	15/08/22	MT
Truist Downgrades Aptinyx to Hold From Buy	15/08/22	MT
BMO Capital Adjusts Price Target on Aptinyx to $2 From $6, Keeps Outperform Rating	15/08/22	MT
Piper Sandler Downgrades Aptinyx to Neutral from Overweight, Adjusts Price Target to $2 from $6	12/08/22	MT
Piper Sandler Adjusts Price Target on Aptinyx to $6 From $10, Reiterates Overweight Rating	19/05/22	MT
SVB Leerink Adjusts Aptinyx Price Target to $4 From $10, Maintains Outperform Rating	21/04/22	MT
HC Wainwright Adjusts Price Target on Aptinyx to $2 From $8, Reiterates Buy Rating	14/04/22	MT
BMO Capital Adjusts Price Target for Aptinyx to $6 From $12, Maintains Outperform Rating	08/04/22	MT
Cantor Fitzgerald Lowers Aptinyx's Price Target to $5 From $11, Maintains Overweight Rating	08/04/22	MT
Truist Securities Adjusts Aptinyx Price Target to $5 From $12, Maintains Buy Rating	08/04/22	MT
William Blair Downgrades Aptinyx to Market Perform From Outperform	07/04/22	MT
Wedbush Cuts Price Target on Aptinyx to $3 From $5, Citing 'Financing Overhang,' Notes 'Disappointing' Data on NYX-2925/DPN; Outperform Rating Kept	07/04/22	MT
Wedbush Cuts Price Target on Aptinyx to $5 From $6 'on Lower Net Cash,' Keeps Outperform Rating	24/03/22	MT
SVB Leerink Adjusts Aptinyx's Price Target to $10 from $12, Keeps Outperform Rating	20/12/21	MT
APTINYX : Wedbush Adjusts Price Target on Aptinyx to $6 From $8, Citing NYX-783 Timeline Adjustment; Outperform Rating Kept	14/05/21	MT
APTINYX : Wedbush Lowers Aptinyx' PT to $8 from $9, Keeps Outperform Rating	25/03/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. APTINYX

Equities

APTX

US03836N1037

Analyst Reco.

Filters